Cipla is currently trading at Rs. 1325.00, up by 3.25 points or 0.25% from its previous closing of Rs. 1321.75 on the BSE.

The scrip opened at Rs. 1311.95 and has touched a high and low of Rs. 1325.00 and Rs. 1292.80 respectively. So far 38176 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1672.20 on 23-Oct-2025 and a 52 week low of Rs. 1283.00 on 27-Jan-2026.

Last one week high and low of the scrip stood at Rs. 1354.15 and Rs. 1292.80 respectively. The current market cap of the company is Rs. 106954.20 crore.

The promoters holding in the company stood at 29.21%, while Institutions and Non-Institutions held 54.64% and 16.14% respectively.

Cipla’s wholly owned subsidiary -- Cipla USA, Inc is recalling over 400 cartons of generic anti-cancer medication, Nilotinib Capsules, due to a manufacturing issue. Cipla USA, Inc has recalled Nilotinib Capsules in two strengths (150 mg and 200 mg). 

On February 18, 2026, Cipla USA, Inc had initiated the Class III voluntary recall. A Class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.

Cipla is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).

Cipla Share Price

1333.10 7.95 (0.60%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1313.90
Cipla 1333.10
Zydus Lifesciences 922.90
Lupin 2340.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×